Ttbio Corp.

Taipei Exchange 6493.TWO

Ttbio Corp. Free Cash Flow Yield on January 13, 2025: -9.20%

Ttbio Corp. Free Cash Flow Yield is -9.20% on January 13, 2025, a -10.09% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Ttbio Corp. 52-week high Free Cash Flow Yield is -7.72% on September 24, 2024, which is 16.11% above the current Free Cash Flow Yield.
  • Ttbio Corp. 52-week low Free Cash Flow Yield is -9.20% on January 13, 2025, which is 0.00% below the current Free Cash Flow Yield.
  • Ttbio Corp. average Free Cash Flow Yield for the last 52 weeks is -8.36%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Taipei Exchange: 6493.TWO

Ttbio Corp.

CEO Shu Rong Yang
IPO Date Jan. 8, 2015
Location
Headquarters No. 07, 6th Road Industry Park
Employees 101
Sector Health Care
Industries
Medical Instruments Pharmaceuticals
Description

Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and internationally. The company offers high and low speed hand piece products, dental spare parts, service rotors, maintenance units, and electric hand piece systems. It also provides precision machined parts and components to various industries, including medical, automotive, aerospace, security, computer components, maintenance parts, and custom machining. The company was founded in 2012 and is based in Taichung, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email